CANCER TREATMENT REVIEWS

简称 CANCER TREAT REV ·ENGLAND ·出版周期 Quarterly ·年均收录 108 篇

10.5

最新影响因子

1.30%

自引率

约25%

投稿难度

平均6月

审稿周期

期刊简介

CANCER TREATMENT REVIEWS是一本专注于癌症治疗领域的国际学术期刊，ISSN号为0305-7372，由Elsevier出版，出版地为荷兰，出版周期为月刊。该期刊的影响因子较高，具体数值需查阅最新JCR报告，属于SCI收录期刊，中科院分区通常位于医学或肿瘤学领域的高分区（如1区或2区）。该期刊为非开放获取（非OA）期刊。其发文特点集中于癌症治疗的临床与转化研究，涵盖新型治疗方法、药物评估、治疗策略优化及循证医学综述等。研究领域包括但不限于化疗、放疗、靶向治疗、免疫治疗及多学科综合治疗。杂志质量较高，审稿严格，但作为非OA期刊，可能存在订阅费用较高的问题，且投稿竞争激烈，录用率相对较低。总体而言，该期刊是癌症治疗领域的重要参考来源，但需注意其非OA属性可能限制部分读者获取全文。

影响因子趋势

近期发表

MTAP loss in non–small-cell lung Cancer and beyond: Therapeutic targeting of the MAT2A–PRMT5 axis 2026-08-29

Glioblastoma and resistance to radiotherapy: role of cancer stem cells subpopulations, hypoxia and therapeutic strategies 2026-08-02

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy 2026-07-16

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception 2026-08-03

Immunotherapy for locally advanced head and neck squamous cell carcinoma: A review 2026-07-13

Editorial Board 2026-09-06

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances 2026-07-27

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study 2026-08-03

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life 2026-07-26

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients 2026-07-27